Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Historical trichomoniasis and pregnancy advice is not represented as current guideline-concordant treatment.
Check source scope before reading a dose
GlobalRPh RX List - FLAGYL
Product / population
Oral metronidazole; selected renal-population guidance, not a dialysis schedule.
Renal method
Mild/moderate impairment versus severe impairment or ESRD.
Source revision
Source revision date not established in selected retrieval.
Retrieved
2026-09-07
Local review status
Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.
GlobalRPh-hosted RX List · Oral metronidazole; selected renal-population guidance, not a dialysis schedule.
Renal method: Mild/moderate impairment versus severe impairment or ESRD. Source date: Source revision date not established in selected retrieval. Retrieved: 2026-09-07
Label mirror, not independent corroboration. This is selected locally stored RX List content. Full monograph import and current official-label review are not implied.
Qualified no-adjustment statement. Apply only to the population, product and renal range described in this source.
Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.
Renal dosing, restrictions and evidence limits
No renal dose adjustment is stated for mild-to-moderate impairment. Metabolites may accumulate with severe impairment or ESRD in patients not receiving hemodialysis; monitor for metronidazole-related adverse effects. Dialysis timing and supplemental-dose decisions require the separate complete source sections and are not inferred from this paragraph.
RDM41-rxlist-metronidazole-9f2eaba68f-C1 · Source locator: Dosage / Use in specific populations: renal impairment
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.